2023.05.31
Events
Article quoted from:
Dr. Kou-Wha, Kuo of G&E Herbal Biotechnology Invited by Tao Sheng-Yang Anti-Cancer Foundation
to Host a Public Health Lecture on Cancer Prevention
Date: May 30
Location: Taichung, Taiwan
Organizer: Tao Sheng-Yang Anti-Cancer Foundation
Lecture Topic:
【Research and Development of the Novel Global Ingredient SR-100 in Cancer Treatment】
About D&E Biotechnology:
G&E Herbal Biotechnology is a publicly listed professional company specializing in plant-based new drug development. It operates a PIC/S GMP-certified pharmaceutical plant, active pharmaceutical ingredient (API) plant, food and supplement plants, and a plant-drug activity and mechanism research center approved by the Chinese Management Science Association. The company develops high-quality plant-based drugs under international pharmaceutical standards, aiming to treat clinically challenging cancers and liver, gallbladder, and kidney diseases.
Global Patents of SR-100:
- Dr. Kuo developed the globally exclusive patented ingredient SR-100.
- The product line includes health and wellness products such as "SR-100 SolaGen Capsule" and "SR-100 Topical Gel".
- SR-100 has received invention patents in dozens of countries, including the USA and EU.
- Phase III clinical trial (code SR-T100) has been completed.
- All products are strictly controlled, free of preservatives and artificial additives, and use natural plant extracts that are safe and gentle.
Product Information:
█ SR-100 SolaGen Capsule
█ SR-100 Topical Gel
█ SR-100 Botanical Skincare GliteR Series